Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. 23 de may. de 2024 · Aclasta (zoledronic acid) inhibits the release of calcium from bones and is used to treat Paget's disease and osteoporosis. Includes Aclasta side effects, interactions and indications.

    • Reviews

      They didn’t tell me to drink lots of water, I read about...

    • Compare Alternatives

      More about Aclasta (zoledronic acid) More about Alendronate...

    • Drug Interactions

      Drugs.com provides accurate and independent information on...

  2. 17 de may. de 2024 · Fever, nausea, constipation, anemia, and shortness of breath are the most frequently reported side effects. Low blood pressure, abdominal pain, and vomiting may also occur. A lowering in the levels of certain electrolytes such as phosphate, potassium, and magnesium may occur.

    • (264)
  3. 16 de may. de 2024 · For the past decades, zoledronic acid (Zol) has been comprehensively approved for its efficacy in reducing the number of vertebral fractures and protecting bone from mineral density loss [3, 4]. Moreover, Zol treatment is also associated with increased bone accretion [ 5 ].

  4. 12 de may. de 2024 · Potent anti-resorptive drugs such as intravenous zoledronic acid have been demonstrated to reduce Modic changes (MCs) upon magnetic resonance imaging (MRI) of the spine and concomitantly decrease associated LBP. It is uncertain whether oral alendronic acid has a similar effect. Methods. 82 subjects were recruited in this case-control study.

  5. Hace 5 días · Zoledronic acid (ZOL) is an anti-osteoporosis drug that usually is given intravenously once yearly. Some studies have shown that more infrequent dosing can provide the same anti-fracture efficacy as once-yearly dosing. The effect of anti-osteoporosis drugs can be measured in a blood sample as they reduce serum levels of the bone marker P1NP.